onabotulinumtoxinA (Botox)

Original post, click here

Generic Name: onabotulinumtoxinA

Brand Name: Botox

Manufacturer: Allergan Inc.

Indications: migraine, chronic

Manufacturer Requested Reimbursement Criteria1:

​For the prophylaxis of headaches in adults with chronic migraine (≥15 days per month with headache lasting 4 hours a day or longer).

Submission Type: Resubmission

Project Status: Pending

Call For Patient Input: September 26, 2018

Patient Input Closed: November 15, 2018

Anticipated Date: October 26, 2018

Biosimilar: No

Fee Schedule: Pending

  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.

Submit Feedback


headache disorders, nervous system